Neuronostics Ltd clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: ECLIPSE · UtiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy Primary and study completion dates pushed to Sep 30, 2027
- Minor: SOLITAIRE · Validate BioEP as an Assessment Aid for Seizure Susceptibility Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Epilepsy (2)
Get alerts when Neuronostics Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.